Legal Representation
Attorney
David Harper
USPTO Deadlines
Application History
25 events| Date | Code | Type | Description |
|---|---|---|---|
| Jan 23, 2017 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Jan 23, 2017 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Jun 21, 2016 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Apr 26, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Apr 26, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Apr 6, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Mar 24, 2016 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Mar 17, 2016 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Mar 17, 2016 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Mar 17, 2016 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Mar 17, 2016 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Mar 17, 2016 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Mar 17, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Mar 15, 2016 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Mar 1, 2016 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Feb 26, 2016 | ALIE | A | ASSIGNED TO LIE |
| Jan 27, 2016 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Jan 27, 2016 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Jan 27, 2016 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Jan 27, 2016 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Jan 27, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jan 26, 2016 | DOCK | D | ASSIGNED TO EXAMINER |
| Oct 14, 2015 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Oct 13, 2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Oct 9, 2015 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 044
Database repository and analysis services used by medical professionals for autoimmune rheumatic disease and autoimmune connective tissue disease diagnosis, disease stratification, prognosis, therapy selection and therapy monitoring; database repository and analysis services for detecting, providing prognosis and monitoring autoimmune rheumatic disease and autoimmune connective tissue disease in patients
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the words "AVISE CORE" in stylized font, with a design of an atomic ring intertwined therein.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
044